Conditions

What are the effects of prescribing sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and multiple risk factors? Type 2 diabetes (T2D) usually occurs with multiple risk factors and complications. When treating patients with T2D targeting several risk factors, especially in the early stages of the disease state, …

The diabetic UK teams developed eight priority questions and recommendations to improve the quality of life and care of older diabetic patients.  Older adults living with diabetes are on the rise, and geriatricians are constantly experiencing difficulties providing care for these patient populations. The challenges may stem from the fact …

Studies have found that there may be a connection between hormone therapy use and type 2 diabetes, putting transgender individuals at an increased risk.   Transgender individuals commonly use hormone therapy to generate the person’s desired physical characteristics. In addition to transforming the individuals’ physical characteristics, hormone therapy can also alter …

The current COVID-19 Pandemic may be to blame for weight gain in patients at a higher risk of developing diabetes. The Healthier You: NHS Diabetes Prevention Program (NHS DPP) developed by the National Health Service (NHS) in 2016 was created to delay or avert the emergence of type 2 diabetes …

Higher consumption of linoleic acid and higher levels in the body may mitigate diabetes mellitus risk. The primary polyunsaturated fatty acid (PUFA) is linoleic acid (LA), an essential fatty acid that makes up 85 to 90% of PUFA dietary consumption in the US. PUFA’s are classified into n-9, n-6, and …

Young age at diagnosis or disease aggression which increases lifetime risk of CKD in type 2 patients with diabetes Type 2 Diabetes, once considered a disease that comes about at an older age, is now increasingly diagnosed in younger adults. The number of people between the ages of 20-39 years …

Metformin is used as first-line therapy but can also be used prophylactically. Almost three-quarters of women who experience gestational diabetes mellitus (GDM) will eventually develop type 2 diabetes (T2DM) in their lifetime. According to Whelan et al., “GDM is one of the most common complications of pregnancy affecting 6-8% of …

The association between anti-diabetic drug use and survival outcomes in patients on dialysis. Diabetic kidney disease that leads to end-stage renal disease (ESRD) and dialysis is common among patients with type 2 diabetes. However, the impact of anti-diabetic drugs on patients undergoing dialysis is rarely studied. Most patients with ESRD …

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients.  Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …

A new treatment is on its way providing superior results for the patients suffering from diabetic foot ulcers. Chronic diabetic foot ulcers (DFUs) account for around 80% of lower limb amputations, resulting in effective medical treatment and cost burdens. Currently, the treatment for DFUs concentrates mainly on local wound care, …